These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1439778)

  • 1. A consensus on reform begins to take shape.
    Hamilton DP
    Science; 1992 Oct; 258(5083):737. PubMed ID: 1439778
    [No Abstract]   [Full Text] [Related]  

  • 2. Consensus conference on indirect costs.
    FASEB J; 1991 Sep; 5(12):2624-37. PubMed ID: 1916086
    [No Abstract]   [Full Text] [Related]  

  • 3. Is the stimulus working for you?
    Freeman R; Block F; Greenberg D; Levi M; Segal AM; Crow M; Teitelbaum MS
    Nature; 2009 Oct; 461(7266):876-8. PubMed ID: 19829353
    [No Abstract]   [Full Text] [Related]  

  • 4. Simplify indirect costs on NIH grants.
    Feigl E
    FASEB J; 1995 Sep; 9(12):1123. PubMed ID: 7672504
    [No Abstract]   [Full Text] [Related]  

  • 5. Management operations of the National Cancer Institute that influence the governance of science.
    Natl Cancer Inst Monogr; 1984 May; 64():1-139. PubMed ID: 6749243
    [No Abstract]   [Full Text] [Related]  

  • 6. NIH readies plan for cost containment.
    Culliton BJ
    Science; 1990 Nov; 250(4985):1198-9. PubMed ID: 2244206
    [No Abstract]   [Full Text] [Related]  

  • 7. Stanford erupts over indirect costs.
    Barinaga M
    Science; 1990 Apr; 248(4953):292-4. PubMed ID: 2326639
    [No Abstract]   [Full Text] [Related]  

  • 8. Status and trends of the NIH extramural research support program.
    Stone RS
    J Med Educ; 1974 Jul; 49(7):637-48. PubMed ID: 4854391
    [No Abstract]   [Full Text] [Related]  

  • 9. Disallowing direct costs.
    Hurley BJ
    Nature; 1992 Feb; 355(6362):668. PubMed ID: 1741050
    [No Abstract]   [Full Text] [Related]  

  • 10. Biomedical research 'revolution' drives push for balanced funding.
    Fintor L
    J Natl Cancer Inst; 2001 Oct; 93(19):1442-3. PubMed ID: 11584054
    [No Abstract]   [Full Text] [Related]  

  • 11. Stepping up the pressure on indirect costs.
    Hamilton DP
    Science; 1992 Feb; 255(5045):679. PubMed ID: 1738838
    [No Abstract]   [Full Text] [Related]  

  • 12. Indirect costs.
    Science; 1991 Apr; 252(5004):359. PubMed ID: 1898439
    [No Abstract]   [Full Text] [Related]  

  • 13. Washington Report. Health and science policies--a look ahead.
    Greenberg DS
    N Engl J Med; 1978 Dec; 299(26):1475-6. PubMed ID: 714144
    [No Abstract]   [Full Text] [Related]  

  • 14. GAO lays out some options.
    Norman C
    Science; 1992 Sep; 257(5075):1340. PubMed ID: 1529330
    [No Abstract]   [Full Text] [Related]  

  • 15. Economic issues in defining stable funding levels for HIV/AIDS research.
    Eastaugh SR
    J Health Adm Educ; 1992; 10(1):139-49. PubMed ID: 10118035
    [No Abstract]   [Full Text] [Related]  

  • 16. Message from the director of the RCMI program.
    McNairy SA
    Cell Mol Biol (Noisy-le-grand); 1995; 41 Suppl 1():Siii-Siv. PubMed ID: 8574135
    [No Abstract]   [Full Text] [Related]  

  • 17. After Katrina. New Orleans labs start their uncertain comeback.
    Kaiser J
    Science; 2005 Nov; 310(5752):1267-9. PubMed ID: 16311313
    [No Abstract]   [Full Text] [Related]  

  • 18. Congress Passes 2006 NIH Reform Act.
    Lang L
    Gastroenterology; 2007 Feb; 132(2):474-5. PubMed ID: 17261310
    [No Abstract]   [Full Text] [Related]  

  • 19. NIH: gearing up for the twenty-first century.
    Baldwin W; McCardle P
    Physiologist; 1997 Jun; 40(3):89, 91-3. PubMed ID: 9230629
    [No Abstract]   [Full Text] [Related]  

  • 20. National expenditures for biomedical research.
    Berliner RW; Kennedy TJ
    J Med Educ; 1970 Sep; 45(9):666-78. PubMed ID: 5454696
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.